Skip to main content
. 2015 Feb 25;34(1):157–164. doi: 10.1007/s10555-015-9552-6

Fig. 1.

Fig. 1

HER2 positivity across cancers: analysis of 37,992 samples by IHC. IHC 3+ was considered HER2 IHC positive